Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01583517 · ClinicalTrials.gov registry record · NA
ERCP in Idiopathic Recurrent Acute Pancreatitis
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
NCT01583517 is a NA study that has completed, run by Indiana University. The registered enrollment target is 89 participants.
The verdict
NCT01583517, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
Study Summary
The therapeutic impact of ERCP with sphincterotomy in the management of patients with idiopathic recurrent acute pancreatitis (RAP) needs further study. The investigators conducted a single center, feasibility, randomized trial to determine 1) the role of pancreatic manometry in predicting future episodes of RAP and 2) differences in the efficacy of no, biliary (BES) or pancreatobiliary (dual) endoscopic sphincterotomy (DES).
Interventions
- PROCEDURE Sham
- PROCEDURE Biliary sphincterotomy
- PROCEDURE Pancreatobiliary sphincterotomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 1997-09 |
| Est. Completion | 2014-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01583517
The ClinicalTrials.gov registry entry for NCT01583517 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sham is the first listed.
NCT01583517 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01583517 about?
NCT01583517 is a clinical study titled "ERCP in Idiopathic Recurrent Acute Pancreatitis". The therapeutic impact of ERCP with sphincterotomy in the management of patients with idiopathic recurrent acute pancreatitis (RAP) needs further study. The investigators conducted a single center, feasibility, randomized trial to determine 1) the role of pancreatic manometry in predicting future ep...
What is the current status of trial NCT01583517?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 1997-09. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01583517?
The interventions under investigation include: Sham (PROCEDURE), Biliary sphincterotomy (PROCEDURE), Pancreatobiliary sphincterotomy (PROCEDURE).
Who is sponsoring clinical trial NCT01583517?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.